| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/05/2011 | CN101537160B Health product for toxicant elimination and beauty maintenance |
| 01/05/2011 | CN101537127B Raw bone meal plaster |
| 01/05/2011 | CN101485735B Medicament composition with stone-eliminating and expelling functions and preparation method thereof |
| 01/05/2011 | CN101417077B Compound buckwheat flower and leaf flavones preparation for controlling diabetes and complicating disease thereof and preparation method thereof |
| 01/05/2011 | CN101371891B Production method of composition of ginseng, astragalus and Ganoderma lucidum |
| 01/05/2011 | CN101342233B Peppermint prescription particle preparation method |
| 01/05/2011 | CN101342195B Preparation method for traditional Chinese medicine micro powder article |
| 01/05/2011 | CN101342174B Phthiobuzonum/diclothane compound topical formulation |
| 01/05/2011 | CN101327259B Medicament for treating protrusion of lumbar vertebral disc |
| 01/05/2011 | CN101322722B Compound carbamylcholine chloride injection for animals and preparation method thereof |
| 01/05/2011 | CN101306187B Topical paste for treating burns and its production method |
| 01/05/2011 | CN101297954B Unbilical medicament for treating cough and preparation thereof |
| 01/05/2011 | CN101264146B Externally-applied Chinese herbal medicine for treating bones and muscles disease and preparation thereof |
| 01/05/2011 | CN101234134B Application of compound isatis root preparation in preparing medicaments for preventing and controlling endotoxaemia |
| 01/05/2011 | CN101229346B Capsule for hepatitis B |
| 01/05/2011 | CN101224226B Novel clinical uses of big nilgiri nettle |
| 01/05/2011 | CN101214290B Powder for dispersing blood stasis |
| 01/05/2011 | CN101208085B Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation |
| 01/05/2011 | CN101185625B Rubitecan sustained-release implant for treating solid tumor |
| 01/05/2011 | CN101181234B Literdinun sustained-release implantation agent for curing entity tumour |
| 01/05/2011 | CN101088534B Medicine composition for treating bone necrosis and its preparation process |
| 01/05/2011 | CN101066253B Slow releasing ranolazine tablet |
| 01/05/2011 | CN101020059B Medicine composition containing docetaxel matter and its preparation process |
| 01/05/2011 | CN101002832B Granulated quickly dissolving medicine for relaxing bowel |
| 01/05/2011 | CN101002823B External use medicine for treating finger nail (ortoenail) mycosis |
| 01/04/2011 | US7865626 Raid storage subsystem using read connection information command to request WWN information for server table and adapter connection table |
| 01/04/2011 | US7863331 micronized fenofibrate, a surfactant and a binding cellulose derivative as a solubilization adjuvant that improves bioavailability; reducing food effect when treating hyperlipemias; FDA Orange book listed patent for fenofibrate |
| 01/04/2011 | US7863326 Pharmaceutical compositions comprising ascorbic acid for the treatment of fungal superinfections and fungal recurrences |
| 01/04/2011 | US7863311 administering sublingually to a horse a semisolid transmucosal gel containing detomidine, hydroxypropyl cellulose, sodium lauryl sulfate, propylene glycol and water for providing sedation and analgesia; rapid onset of action, low irritation potential in the oral mucosa |
| 01/04/2011 | US7863287 Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines |
| 01/04/2011 | US7863260 for improving microcirculation in peripheral arterial occlusive disease; maintaining normovolemia; pharmacokinetic; for therapeutic hemodilution in disturbed blood supply and arterial, especially peripheral arterial, occlusive diseases; NaCl, MgCl, KCl, CaCl2 as active ingredients |
| 01/04/2011 | US7863256 Amide derivatives of hyaluronic acid in osteoarthrosis |
| 01/04/2011 | US7863246 intracerebroventricular delivery of low amounts of vascular endothelial growth factor for enhancing the survival of a motor neuron in a patient diagnosed with a motoneuron disease |
| 01/04/2011 | US7863245 Compositions for enhanced epithelial permeation of neuropeptide Y for treating obesity |
| 01/04/2011 | US7863241 Lung surfactant polypeptide, and at least one inhibitor of a mediator of tissue destruction; for example protease inhibitors; treating inflammatory lung conditions such as asthma, chronic obstructive pulmonary disease |
| 01/04/2011 | US7863047 Intracorporeal medicaments for photodynamic treatment of disease |
| 01/04/2011 | US7863045 Using cartilage-derived morphogenic protein-1 (CDMP-1) expression profiles to identify viable, expanded or passaged, committed skeletal precursor cells capable of differentiating into skeletal tissues; bone and/or tissue regeneration |
| 01/04/2011 | US7862835 Method of manufacturing a medical device having a porous coating thereon |
| 01/04/2011 | US7862834 Pharmaceutical formulation comprising a water-insoluble active agent |
| 01/04/2011 | US7862833 for buccal, gingival and/or sublingual administration; effervescence acts as a penetration enhancer; pH adjusting substances |
| 01/04/2011 | US7862832 Generally linear effervescent oral fentanyl dosage form and methods of administering |
| 01/04/2011 | US7862807 Biologically active molecule bonded to a dendrimer having a guanidine, protonated guanidine, protected guanidine, amidine, protonated amidine group, ureido, at protonated ureido group, protected ureido, a thioureido group, and a protonated thioureido goup; increasing the bioavailability of a drug |
| 01/04/2011 | US7862751 solid (cyclosporine, gemfibrozil or fenofibrate) melts under pressure of gas without degrading at temperature lower than melting point, forming solution with carrier, passing through vessel of lower pressure to form particles; encapsulated with biodegradable polyoxyethylene glycol, cellulose acetate |
| 01/04/2011 | US7862552 Medical devices for treating urological and uterine conditions |
| 01/04/2011 | US7862545 Pivoting joint infusion system with steal |
| 01/04/2011 | US7861957 Particle-size reduction apparatus, and use thereof |
| 01/04/2011 | US7861712 Sealed capsule including an integrated puncturing mechanism |
| 01/04/2011 | CA2573307C Use of platelet aggregation inhibitors |
| 01/04/2011 | CA2543722C Tocopherol-modified therapeutic drug compounds |
| 01/04/2011 | CA2532631C Nasal pharmaceutical composition of piribedil |
| 01/04/2011 | CA2513708C Formulation and methods for the treatment of thrombocythemia |
| 01/04/2011 | CA2488124C Vitamin a liposomes and the method of its preparation |
| 01/04/2011 | CA2486654C Delivery system for flowable medicinal or therapeutic substances |
| 01/04/2011 | CA2481754C Antibiotic/benzoyl peroxide dispenser |
| 01/04/2011 | CA2479638C Hfa-suspension formulations of crystalline tiotropium bromide anhydrate |
| 01/04/2011 | CA2474343C Nsaid-containing topical formulations that demonstrate chemopreventive activity |
| 01/04/2011 | CA2463259C Chewable tablet containing lysine |
| 01/04/2011 | CA2460920C Stent coated with a sustained-release drug delivery and method for use thereof |
| 01/04/2011 | CA2455933C Soluble roasted chicory having high inulin content |
| 01/04/2011 | CA2450943C Tooth whitening chewing gum |
| 01/04/2011 | CA2449054C Integrin targeting liposome for nucleic acid delivery |
| 01/04/2011 | CA2444569C A novel coating for a sustained release pharmaceutical composition |
| 01/04/2011 | CA2443728C Pharmaceutical composition based on macrolides for topical application in ophthalmology |
| 01/04/2011 | CA2429486C O/w emulsion composition and method of preparing the same |
| 01/04/2011 | CA2396554C Physiologically active agents containing vicinal dithioglycols and use thereof in various branches of economy |
| 01/04/2011 | CA2396165C Airway alkalinization as therapy for airway diseases |
| 01/04/2011 | CA2388609C Oxcarbazepine formulations for administration with or without food |
| 01/04/2011 | CA2384670C Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions |
| 01/04/2011 | CA2379909C Drug releasing biodegradable fiber implant |
| 01/04/2011 | CA2360692C Noninvasive vaccination through the skin |
| 01/04/2011 | CA2335702C Hydrophilic polymer blends used to prevent cow skin infections |
| 01/04/2011 | CA2333317C Stable oil-in-glycerin emulsion |
| 01/04/2011 | CA2319672C Compounds and compositions for delivering active agents |
| 01/04/2011 | CA2307000C Veterinary vaccines |
| 01/04/2011 | CA2301920C Vaccine |
| 01/04/2011 | CA2246747C Method of promoting bone growth with hyaluronic acid and growth factors |
| 01/04/2011 | CA2217191C Pharmaceutical composition containing pectin and a phospholipid, used as an antidiarrheal and antiulcer agent |
| 12/30/2010 | US20100333221 Mutated hyperthermophilic phosphotriesterases and uses thereof |
| 12/30/2010 | US20100331819 Drug Delivery System and Method of Treatment of Vascular Diseases Using Photodynamic Therapy |
| 12/30/2010 | US20100331423 Aqueous solution of olanexidine, method of preparing the aqueous solution, and disinfectant |
| 12/30/2010 | US20100331421 Disinfectant and/or bactericidal aqueous compositions |
| 12/30/2010 | US20100331407 Clear ophthalmic solution comprising latanoprost as active ingredient |
| 12/30/2010 | US20100331395 Decoy-containing pharmaceutical compositions and method of using the same |
| 12/30/2010 | US20100331382 Processes of making and using pharmaceutical formulations of antineoplastic agents |
| 12/30/2010 | US20100331354 Intranasal Opioid Compositions |
| 12/30/2010 | US20100331289 Combination of Azelastine and Steroids |
| 12/30/2010 | US20100331253 Method for cell adhesion and wound healing |
| 12/30/2010 | US20100331252 Myostatin inhibitor enhancement of musculoskeletal repair |
| 12/30/2010 | US20100331202 Nanotube structures having a surfactant bilayer inner wall coating |
| 12/30/2010 | US20100331177 Amorphous silica particles having high absorbing capabilities and high structural characteristics |
| 12/30/2010 | US20100330191 Diaminooxidase-containing pharmaceutical compositions |
| 12/30/2010 | US20100330190 Immunogenic compositions and methods of use thereof |
| 12/30/2010 | US20100330189 Sustained release beads and suspensions including the same for sustained delivery of active ingredients |
| 12/30/2010 | US20100330188 Carrier particles for use in dry powder inhalers |
| 12/30/2010 | US20100330187 Capsicum food additive and uses thereof |
| 12/30/2010 | US20100330186 Medicaments for inhalation comprising an anticholinergic and a betamimetic |
| 12/30/2010 | US20100330184 Injection vehicle for polymer-based formulations |
| 12/30/2010 | US20100330183 Solid dispersing vaccine composition for oral delivery |
| 12/30/2010 | US20100330182 Tendon Stem Cells |
| 12/30/2010 | US20100330181 Biphasic implant device providing gradient |